Marshall Wace North America’s STAAR Surgical STAA Stock Holding History

Marshall Wace North America’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$11.5M	Buy	89,445 +6,396	+8%	+$895K	0.05%	324
2021 Q2	$12.7M	Sell	83,049 -69,853	-46%	-$9.2M	0.05%	335
2021 Q1	$16.1M	Buy	+152,902	New	+$15.3M	0.07%	297
2020 Q2	–	Sell	-21,989	Closed	-$710K	–	1463
2020 Q1	$710K	Buy	+21,989	New	+$741K	0.01%	687
2019 Q4	–	Sell	-67,868	Closed	-$1.75M	–	1579
2019 Q3	$1.75M	Sell	67,868 -19,376	-22%	-$589K	0.01%	571
2019 Q2	$2.56M	Buy	87,244 +72,763	+502%	+$2.1M	0.02%	507
2019 Q1	$495K	Buy	14,481 +3,086	+27%	+$109K	﹤0.01%	808
2018 Q4	$364K	Sell	11,395 -242,141	-96%	-$9.44M	﹤0.01%	844
2018 Q3	$12.2M	Buy	+253,536	New	+$10.4M	0.08%	191
2018 Q2	–	Sell	-18,644	Closed	-$276K	–	1665
2018 Q1	$276K	Buy	+18,644	New	+$291K	﹤0.01%	1274

Other funds holding STAA

Broadwood Capital New York $1.91B AUM 44.39% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Marshall Wace North America's STAA Position: Q3 2021 in Review

Marshall Wace North America increased its STAAR Surgical (STAA) stake by 7.7% in Q3 2021, buying an estimated $895K and bringing the position to 89,445 shares worth $11.5M. The position accounts for 0.05% of the portfolio, ranked #324.

Marshall Wace North America first reported a position in STAA in Q1 2018 and has held it in 10 quarters since. The position peaked at $16.1M in Q1 2021. 291 funds tracked by Wall St. Rank hold STAA as of Q3 2021.

Marshall Wace North America held 89,445 shares of STAAR Surgical worth $11.5M as of Q3 2021.
Marshall Wace North America bought 6,396 STAAR Surgical shares in Q3 2021, an estimated $895K.
STAAR Surgical made up 0.05% of Marshall Wace North America's portfolio in Q3 2021, its #324 holding.
Marshall Wace North America first reported a position in STAAR Surgical in Q1 2018 and has held it in 10 quarters since.
Marshall Wace North America's STAAR Surgical position peaked at $16.1M in Q1 2021.
291 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.